Related Experiment Video

Updated: Jun 24, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Response to Panteghini "About Analytical Performance Specifications for Immunosuppressive Drug Measurements"

Maria Shipkova1, Eberhard Wieland1, Ekkerhard Schütz2

  • 1Bioscientia Institut für Medizinische Diagnostik, Ingelheim, Germany; and.

Therapeutic Drug Monitoring
|June 22, 2026
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Experiment Videos

Last Updated: Jun 24, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Concept Videos

Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

Articles linked to this work by shared authors, journal, and citation graph.

First performance verification of automated cobas® i601 LC-MS/MS in a high-throughput clinical laboratory using 25-hydroxyvitamin D, 5α-dihydrotestosterone, and 17α-hydroxyprogesterone.

Clinical chemistry and laboratory medicine·2026

Improving diagnostic performance of kidney allograft rejection with a model combining relative fraction and absolute copies of donor-derived cell-free DNA-Results from 5 independent cohorts.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

To Convert or Not to Convert? Official International Association of Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Considerations and Recommendations for Converting Capillary Blood Microsampling Concentrations to Plasma Concentrations.

Therapeutic drug monitoring·2025

[Analysis of lipid levels in medical laboratories in Germany from 2017 to 2022 considering the impact of COVID-19 lockdown measures].

Wiener medizinische Wochenschrift (1946)·2025

Toward Analytical Performance Specifications for Immunosuppressive Drug Quantification in Transplantation: An Opinion Article.

Therapeutic drug monitoring·2024

Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Therapeutic drug monitoring·2024

KCNA3 Gene Polymorphism Affects the Efficacy and Plasma Concentration of Perampanel in Patients With Refractory Epilepsy.

Therapeutic drug monitoring·2026

Early Tacrolimus Underexposure Predicts Acute Rejection After Renal Transplantation.

Therapeutic drug monitoring·2026

Optimizing Immunosuppressant Transition Strategies: Population Pharmacokinetic Analysis of Tacrolimus to Sirolimus Conversion in Renal Transplantation.

Therapeutic drug monitoring·2026

High-throughput UHPLC-MS/MS Assay for the Quantification of Venetoclax in Patients with Acute Myeloid Leukemia and Assessment of Clinical Application: A Short Communication.

Therapeutic drug monitoring·2026

A Retrospective Analysis of Itraconazole and Hydroxy-Itraconazole Serum Concentrations Correlation to Clinical Outcomes of Histoplasmosis Treatment.

Therapeutic drug monitoring·2026

Apparent Elevation of Whole-Blood Tacrolimus Concentrations Following High-Dose Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.

Therapeutic drug monitoring·2026

Transitions From Parenteral Prostacyclin Analogues to Selexipag in Patients With Pulmonary Arterial Hypertension.

Pulmonary circulation·2026

A DoE-Dual centrifugation-driven screening platform for liposomal incorporation of poorly soluble APIs: Application to the PROTAC ACBI2.

International journal of pharmaceutics: X·2026

Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence.

Frontiers in aging·2026

Exploring the Polyethylene Glycol-Modified Drug Patent Landscape by Deep Learning.

Therapeutic innovation & regulatory science·2026

Bridging in vitro buoyancy to clinical performance: A PBPK-driven analysis of once-daily Bepotastine gastro-retentive tablet in beagles and humans.

Journal of controlled release : official journal of the Controlled Release Society·2026

Differential Oral Absorption Pharmacokinetics of Tacrolimus in Simultaneous Kidney-Pancreas Transplant Compared to Kidney Transplant Recipients.

Clinical pharmacokinetics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us